مصطلحات الفهرس: convalescent plasma/dt [Drug Therapy], azithromycin/dt [Drug Therapy], azithromycin/pv [Special Situation for Pharmacovigilance], baloxavir marboxil/dt [Drug Therapy], baloxavir marboxil/pv [Special Situation for Pharmacovigilance], beta1a interferon/dt [Drug Therapy], beta1a interferon/pv [Special Situation for Pharmacovigilance], calcifediol/dt [Drug Therapy], calcifediol/pv [Special Situation for Pharmacovigilance], chloroquine/dt [Drug Therapy], chloroquine/pv [Special Situation for Pharmacovigilance], cobicistat plus darunavir/dt [Drug Therapy], cobicistat plus darunavir/pv [Special Situation for Pharmacovigilance], colchicine/dt [Drug Therapy], colchicine/pv [Special Situation for Pharmacovigilance], convalescent plasma/pv [Special Situation for Pharmacovigilance], corticosteroid/dt [Drug Therapy], corticosteroid/pv [Special Situation for Pharmacovigilance], daclatasvir/cb [Drug Combination], daclatasvir/dt [Drug Therapy], daclatasvir/pv [Special Situation for Pharmacovigilance], dalteparin/dt [Drug Therapy], dalteparin/pv [Special Situation for Pharmacovigilance], enoxaparin/pv [Special Situation for Pharmacovigilance], favipiravir/dt [Drug Therapy], favipiravir/pv [Special Situation for Pharmacovigilance], gamma interferon/dt [Drug Therapy], gamma interferon/pv [Special Situation for Pharmacovigilance], hydroxychloroquine/dt [Drug Therapy], immunoglobulin/cb [Drug Combination], immunoglobulin/dt [Drug Therapy], immunoglobulin/pv [Special Situation for Pharmacovigilance], interferon beta serine/dt [Drug Therapy], interferon beta serine/pv [Special Situation for Pharmacovigilance], lopinavir plus ritonavir/dt [Drug Therapy], lopinavir plus ritonavir/pv [Special Situation for Pharmacovigilance], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], methylprednisolone/pv [Special Situation for Pharmacovigilance], prednisolone/dt [Drug Therapy], prednisolone/pv [Special Situation for Pharmacovigilance], remdesivir/dt [Drug Therapy], remdesivir/pv [Special Situation for Pharmacovigilance], ruxolitinib/dt [Drug Therapy], ruxolitinib/pv [Special Situation for Pharmacovigilance], sofosbuvir/cb [Drug Combination], sofosbuvir/dt [Drug Therapy], sofosbuvir/pv [Special Situation for Pharmacovigilance], telmisartan/dt [Drug Therapy], telmisartan/pv [Special Situation for Pharmacovigilance], umifenovir/dt [Drug Therapy], umifenovir/pv [Special Situation for Pharmacovigilance], face mask, dexamethasone/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/pv [Special Situation for Pharmacovigilance], enoxaparin/dt [Drug Therapy], anticoagulant therapy, article, assisted ventilation, Australia, birth, breast feeding, clinical decision making, clinical trial (topic), clinician, controlled study, coronavirus disease 2019/dt [Drug Therapy], coronavirus disease 2019/pc [Prevention], coronavirus disease 2019/th [Therapy], corticosteroid therapy, data collection method, data synthesis, disease surveillance, evidence based medicine, extracorporeal oxygenation, female, hand washing, human, maternal care, maternal hypertension/dt [Drug Therapy], mesenchymal stem cell transplantation, post exposure prophylaxis, practice guideline, pregnant woman, prenatal period, priority journal, prone position, puerperium, rooming in, skin, systematic review, thrombosis prevention, umbilical cord, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], aprepitant/dt [Drug Therapy], aprepitant/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28655Test
Australian and New Zealand Journal of Obstetrics and Gynaecology
Click here for full text options
LibKey Link

مصطلحات الفهرس: convalescent plasma/dt [Drug Therapy], azithromycin/dt [Drug Therapy], azithromycin/pv [Special Situation for Pharmacovigilance], baloxavir marboxil/dt [Drug Therapy], baloxavir marboxil/pv [Special Situation for Pharmacovigilance], beta1a interferon/dt [Drug Therapy], beta1a interferon/pv [Special Situation for Pharmacovigilance], calcifediol/dt [Drug Therapy], calcifediol/pv [Special Situation for Pharmacovigilance], chloroquine/dt [Drug Therapy], chloroquine/pv [Special Situation for Pharmacovigilance], cobicistat plus darunavir/dt [Drug Therapy], cobicistat plus darunavir/pv [Special Situation for Pharmacovigilance], colchicine/dt [Drug Therapy], colchicine/pv [Special Situation for Pharmacovigilance], convalescent plasma/pv [Special Situation for Pharmacovigilance], corticosteroid/dt [Drug Therapy], corticosteroid/pv [Special Situation for Pharmacovigilance], daclatasvir/cb [Drug Combination], daclatasvir/dt [Drug Therapy], daclatasvir/pv [Special Situation for Pharmacovigilance], dalteparin/dt [Drug Therapy], dalteparin/pv [Special Situation for Pharmacovigilance], enoxaparin/pv [Special Situation for Pharmacovigilance], favipiravir/dt [Drug Therapy], favipiravir/pv [Special Situation for Pharmacovigilance], gamma interferon/dt [Drug Therapy], gamma interferon/pv [Special Situation for Pharmacovigilance], hydroxychloroquine/dt [Drug Therapy], immunoglobulin/cb [Drug Combination], immunoglobulin/dt [Drug Therapy], immunoglobulin/pv [Special Situation for Pharmacovigilance], interferon beta serine/dt [Drug Therapy], interferon beta serine/pv [Special Situation for Pharmacovigilance], lopinavir plus ritonavir/dt [Drug Therapy], lopinavir plus ritonavir/pv [Special Situation for Pharmacovigilance], methylprednisolone/cb [Drug Combination], methylprednisolone/dt [Drug Therapy], methylprednisolone/pv [Special Situation for Pharmacovigilance], prednisolone/dt [Drug Therapy], prednisolone/pv [Special Situation for Pharmacovigilance], remdesivir/dt [Drug Therapy], remdesivir/pv [Special Situation for Pharmacovigilance], ruxolitinib/dt [Drug Therapy], ruxolitinib/pv [Special Situation for Pharmacovigilance], sofosbuvir/cb [Drug Combination], sofosbuvir/dt [Drug Therapy], sofosbuvir/pv [Special Situation for Pharmacovigilance], telmisartan/dt [Drug Therapy], telmisartan/pv [Special Situation for Pharmacovigilance], umifenovir/dt [Drug Therapy], umifenovir/pv [Special Situation for Pharmacovigilance], face mask, dexamethasone/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/dt [Drug Therapy], dipeptidyl carboxypeptidase inhibitor/pv [Special Situation for Pharmacovigilance], enoxaparin/dt [Drug Therapy], anticoagulant therapy, article, assisted ventilation, Australia, birth, breast feeding, clinical decision making, clinical trial (topic), clinician, controlled study, coronavirus disease 2019/dt [Drug Therapy], coronavirus disease 2019/pc [Prevention], coronavirus disease 2019/th [Therapy], corticosteroid therapy, data collection method, data synthesis, disease surveillance, evidence based medicine, extracorporeal oxygenation, female, hand washing, human, maternal care, maternal hypertension/dt [Drug Therapy], mesenchymal stem cell transplantation, post exposure prophylaxis, practice guideline, pregnant woman, prenatal period, priority journal, prone position, puerperium, rooming in, skin, systematic review, thrombosis prevention, umbilical cord, venous thromboembolism/dt [Drug Therapy], venous thromboembolism/pc [Prevention], aprepitant/dt [Drug Therapy], aprepitant/pv [Special Situation for Pharmacovigilance], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/28655Test
Australian and New Zealand Journal of Obstetrics and Gynaecology
LibKey Link

مصطلحات الفهرس: multiple sclerosis/pc [Prevention], priority journal, retrospective study, unspecified side effect/si [Side Effect], acetylsalicylic acid/dt [Drug Therapy], alemtuzumab/dt [Drug Therapy], antacid agent, antidiarrheal agent, antihistaminic agent, beta1a interferon/dt [Drug Therapy], fingolimod/dt [Drug Therapy], fumaric acid dimethyl ester/ae [Adverse Drug Reaction], fumaric acid dimethyl ester/dt [Drug Therapy], glatiramer/dt [Drug Therapy], interferon beta serine/dt [Drug Therapy], natalizumab/dt [Drug Therapy], proton pump inhibitor, serotonin 3 antagonist, teriflunomide/dt [Drug Therapy], female, abdominal pain/dt [Drug Therapy], adult, article, disease duration, disease severity, drug efficacy, drug safety, drug withdrawal, flushing, gastrointestinal disease, human, major clinical study, male, multiple sclerosis/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35363Test
Neurology and Therapy
Click here for full text options
LibKey Link

مصطلحات الفهرس: multiple sclerosis/pc [Prevention], priority journal, retrospective study, unspecified side effect/si [Side Effect], acetylsalicylic acid/dt [Drug Therapy], alemtuzumab/dt [Drug Therapy], antacid agent, antidiarrheal agent, antihistaminic agent, beta1a interferon/dt [Drug Therapy], fingolimod/dt [Drug Therapy], fumaric acid dimethyl ester/ae [Adverse Drug Reaction], fumaric acid dimethyl ester/dt [Drug Therapy], glatiramer/dt [Drug Therapy], interferon beta serine/dt [Drug Therapy], natalizumab/dt [Drug Therapy], proton pump inhibitor, serotonin 3 antagonist, teriflunomide/dt [Drug Therapy], female, abdominal pain/dt [Drug Therapy], adult, article, disease duration, disease severity, drug efficacy, drug safety, drug withdrawal, flushing, gastrointestinal disease, human, major clinical study, male, multiple sclerosis/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/35363Test
Neurology and Therapy
LibKey Link

مصطلحات الفهرس: letter, lung edema, malignant hypertension/dt [Drug Therapy], middle aged, multiple sclerosis/dt [Drug Therapy], priority journal, hemolysis, human tissue, kidney biopsy, acute kidney failure, adult, case report, clinical article, creatinine blood level, drug withdrawal, dyspnea, female, human, proteinuria, thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/si [Side Effect], antihypertensive agent/dt [Drug Therapy], beta1a interferon/ae [Adverse Drug Reaction], beta1a interferon/dt [Drug Therapy], beta1a interferon/sc [Subcutaneous Drug Administration], creatinine/ec [Endogenous Compound], teriflunomide/dt [Drug Therapy], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36225Test
Internal Medicine Journal
Click here for full text options
LibKey Link

مصطلحات الفهرس: letter, lung edema, malignant hypertension/dt [Drug Therapy], middle aged, multiple sclerosis/dt [Drug Therapy], priority journal, hemolysis, human tissue, kidney biopsy, acute kidney failure, adult, case report, clinical article, creatinine blood level, drug withdrawal, dyspnea, female, human, proteinuria, thrombotic thrombocytopenic purpura/di [Diagnosis], thrombotic thrombocytopenic purpura/si [Side Effect], antihypertensive agent/dt [Drug Therapy], beta1a interferon/ae [Adverse Drug Reaction], beta1a interferon/dt [Drug Therapy], beta1a interferon/sc [Subcutaneous Drug Administration], creatinine/ec [Endogenous Compound], teriflunomide/dt [Drug Therapy], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/36225Test
Internal Medicine Journal
LibKey Link

مصطلحات الفهرس: fingolimod/cm [Drug Comparison], adult, article, cohort analysis, controlled study, drug efficacy, drug exposure, female, follow up, human, major clinical study, male, middle aged, multiple sclerosis/dt [Drug Therapy], sensitivity analysis, treatment duration, treatment outcome, beta1a interferon/cm [Drug Comparison], beta1a interferon/dt [Drug Therapy], beta1a interferon/sc [Subcutaneous Drug Administration], cladribine/cm [Drug Comparison], cladribine/dt [Drug Therapy], cladribine/po [Oral Drug Administration], fingolimod/dt [Drug Therapy], fingolimod/po [Oral Drug Administration], natalizumab/cm [Drug Comparison], natalizumab/dt [Drug Therapy], natalizumab/iv [Intravenous Drug Administration], recombinant beta interferon, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38597Test
Multiple Sclerosis Journal
Click here for full text options
LibKey Link

مصطلحات الفهرس: fingolimod/cm [Drug Comparison], adult, article, cohort analysis, controlled study, drug efficacy, drug exposure, female, follow up, human, major clinical study, male, middle aged, multiple sclerosis/dt [Drug Therapy], sensitivity analysis, treatment duration, treatment outcome, beta1a interferon/cm [Drug Comparison], beta1a interferon/dt [Drug Therapy], beta1a interferon/sc [Subcutaneous Drug Administration], cladribine/cm [Drug Comparison], cladribine/dt [Drug Therapy], cladribine/po [Oral Drug Administration], fingolimod/dt [Drug Therapy], fingolimod/po [Oral Drug Administration], natalizumab/cm [Drug Comparison], natalizumab/dt [Drug Therapy], natalizumab/iv [Intravenous Drug Administration], recombinant beta interferon, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/38597Test
Multiple Sclerosis Journal
Click here for full text options
LibKey Link

مصطلحات الفهرس: electrocardiography, Expanded Disability Status Scale, heart atrium enlargement/di [Diagnosis], heart catheterization, heart right atrium pressure, histopathology, human, human tissue, hypertrophy, hypoxemia/th [Therapy], immunosuppressive treatment, long term care, lung diffusion capacity, lung transplantation, lung vascular resistance, lung wedge pressure, maximum tolerated dose, middle aged, multiple sclerosis/di [Diagnosis], multiple sclerosis/dt [Drug Therapy], New York Heart Association class, oxygen therapy, pulmonary hypertension/di [Diagnosis], pulmonary hypertension/dt [Drug Therapy], pulmonary hypertension/si [Side Effect], beta1a interferon/dt [Drug Therapy], bosentan/dt [Drug Therapy], diltiazem/dt [Drug Therapy], fingolimod/dt [Drug Therapy], hematoxylin, hydrochlorothiazide/dt [Drug Therapy], perindopril/dt [Drug Therapy], prostacyclin/dt [Drug Therapy], prostacyclin/iv [Intravenous Drug Administration], sildenafil/dt [Drug Therapy], sildenafil/iv [Intravenous Drug Administration], sitaxsentan/dt [Drug Therapy], sitaxsentan/iv [Intravenous Drug Administration], teriflunomide/dt [Drug Therapy], warfarin/dt [Drug Therapy], heart right atrium enlargement/di [Diagnosis], heart right ventricular systolic dysfunction/di [Diagnosis], female, risk factor, six minute walk test, thorax radiography, transthoracic echocardiography, treatment duration, ambrisentan/dt [Drug Therapy], beta1a interferon/ae [Adverse Drug Reaction], adult, article, cardiomegaly, case report, clinical article, drug substitution, drug tolerability, dyspnea, echocardiography, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39587Test
Multiple Sclerosis Journal
Click here for full text options
LibKey Link

مصطلحات الفهرس: electrocardiography, Expanded Disability Status Scale, heart atrium enlargement/di [Diagnosis], heart catheterization, heart right atrium pressure, histopathology, human, human tissue, hypertrophy, hypoxemia/th [Therapy], immunosuppressive treatment, long term care, lung diffusion capacity, lung transplantation, lung vascular resistance, lung wedge pressure, maximum tolerated dose, middle aged, multiple sclerosis/di [Diagnosis], multiple sclerosis/dt [Drug Therapy], New York Heart Association class, oxygen therapy, pulmonary hypertension/di [Diagnosis], pulmonary hypertension/dt [Drug Therapy], pulmonary hypertension/si [Side Effect], beta1a interferon/dt [Drug Therapy], bosentan/dt [Drug Therapy], diltiazem/dt [Drug Therapy], fingolimod/dt [Drug Therapy], hematoxylin, hydrochlorothiazide/dt [Drug Therapy], perindopril/dt [Drug Therapy], prostacyclin/dt [Drug Therapy], prostacyclin/iv [Intravenous Drug Administration], sildenafil/dt [Drug Therapy], sildenafil/iv [Intravenous Drug Administration], sitaxsentan/dt [Drug Therapy], sitaxsentan/iv [Intravenous Drug Administration], teriflunomide/dt [Drug Therapy], warfarin/dt [Drug Therapy], heart right atrium enlargement/di [Diagnosis], heart right ventricular systolic dysfunction/di [Diagnosis], female, risk factor, six minute walk test, thorax radiography, transthoracic echocardiography, treatment duration, ambrisentan/dt [Drug Therapy], beta1a interferon/ae [Adverse Drug Reaction], adult, article, cardiomegaly, case report, clinical article, drug substitution, drug tolerability, dyspnea, echocardiography, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/39587Test
Multiple Sclerosis Journal
Click here for full text options
LibKey Link